Icon Wealth Partners’s Avenue Therapeutics ATXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-533
Closed -$46.6K – 435
2023
Q1
$46.6K Buy
+533
New +$49.2K 0.01% 417

Other funds holding ATXI

Icon Wealth Partners's ATXI Position: Q2 2023 in Review

Icon Wealth Partners sold out of Avenue Therapeutics (ATXI) in Q2 2023, closing a stake of 533 shares — an estimated $46.6K sold.

Icon Wealth Partners first reported a position in ATXI in Q1 2023 and held it in 1 quarter. The position peaked at $46.6K in Q1 2023. 11 funds tracked by Wall St. Rank hold ATXI as of Q2 2023.

  • Icon Wealth Partners reported no remaining Avenue Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Icon Wealth Partners sold 533 Avenue Therapeutics shares in Q2 2023, an estimated $46.6K.
  • Icon Wealth Partners first reported a position in Avenue Therapeutics in Q1 2023 and held it in 1 quarter.
  • Icon Wealth Partners's Avenue Therapeutics position peaked at $46.6K in Q1 2023.
  • 11 funds tracked by Wall St. Rank held Avenue Therapeutics as of Q2 2023.

Based on Icon Wealth Partners's 13F filing for Q2 2023, filed 3 Aug 2023.